The hydrophobic tail of a pH-sensitive cationic lipid influences siRNA transfection activity and toxicity in human NK cell lines

被引:30
作者
Nakamura, Takashi [1 ]
Nakade, Taisei [1 ]
Yamada, Koharu [1 ]
Sato, Yusuke [1 ]
Harashima, Hideyoshi [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan
关键词
Non-viral; Lipid nanoparticle; siRNA; pH-sensitive cationic lipid; NK cell; NK-92; INTRACELLULAR DELIVERY; NANOPARTICLES; CANCER; IMMUNOTHERAPY; DESIGN; NK-92;
D O I
10.1016/j.ijpharm.2021.121140
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The use of natural killer (NK) cells in cell therapy is an attractive next generation strategy for cancer immunotherapy. NK-92 cells (a human NK cell line) have been tested in clinical trial stages, making them an off-theshelf medicine. Controlling gene expression in NK-92 cells by an artificial delivery system is an available for enhancing NK-92 cell therapy. We report here on the development of a siRNA-loaded lipid nanoparticle (LNP) composed of CL1H6 (CL1H6-LNP), an optimized, pH-sensitive cationic lipid, with efficient gene silencing and low cytotoxicity in NK-92 cells. The hydrophilic head group of the lipid molecule used in preparing these particles largely influences the pKa of the final LNP, and lipids with an amino moiety substituted with a methyl group showed a high gene silencing activity. Compared with myristate and palmitate, the hydrophobic tail of oleate had a high gene silencing activity and cell viability. Analyses of intracellular trafficking indicated that the CL1H6-LNP appeared to escape from the endosomes via membrane fusion, without disrupting the membrane. The mechanism of endosomal escape should contribute to our understanding of efficient gene silencing with a low degree of cytotoxicity. These results therefore suggest that a CL1H6-LNP has promise for delivering siRNA to NK-92 cells.
引用
收藏
页数:11
相关论文
共 31 条
[1]   A combinatorial library of lipid-like materials for delivery of RNAi therapeutics [J].
Akinc, Akin ;
Zumbuehl, Andreas ;
Goldberg, Michael ;
Leshchiner, Elizaveta S. ;
Busini, Valentina ;
Hossain, Naushad ;
Bacallado, Sergio A. ;
Nguyen, David N. ;
Fuller, Jason ;
Alvarez, Rene ;
Borodovsky, Anna ;
Borland, Todd ;
Constien, Rainer ;
de Fougerolles, Antonin ;
Dorkin, J. Robert ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
John, Matthias ;
Koteliansky, Victor ;
Manoharan, Muthiah ;
Nechev, Lubomir ;
Qin, June ;
Racie, Timothy ;
Raitcheva, Denitza ;
Rajeev, Kallanthottathil G. ;
Sah, Dinah W. Y. ;
Soutschek, Juergen ;
Toudjarska, Ivanka ;
Vornlocher, Hans-Peter ;
Zimmermann, Tracy S. ;
Langer, Robert ;
Anderson, Daniel G. .
NATURE BIOTECHNOLOGY, 2008, 26 (05) :561-569
[2]   Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial [J].
Arai, S. ;
Meagher, R. ;
Swearingen, M. ;
Myint, H. ;
Rich, E. ;
Martinson, J. ;
Klingemann, H. .
CYTOTHERAPY, 2008, 10 (06) :625-632
[3]   Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia [J].
Boyiadzis, Michael ;
Agha, Mounzer ;
Redner, Robert L. ;
Sehgal, Alison ;
Im, Annie ;
Hou, Jing-Zhou ;
Farah, Rafic ;
Dorritie, Kathleen A. ;
Raptis, Anastasios ;
Lim, Seah H. ;
Wang, Hong ;
Lapteva, Natalia ;
Mei, Zhuyong ;
Butterfield, Lisa H. ;
Rooney, Cliona M. ;
Whiteside, Theresa L. .
CYTOTHERAPY, 2017, 19 (10) :1225-1232
[4]   Signal Transducer and Activator of Transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) Balance Controls Cytotoxicity and IL-10 Expression in Decidual-Like Natural Killer Cell Line NK-92 [J].
Braunschweig, Anne ;
Poehlmann, Tobias G. ;
Busch, Susann ;
Schleussner, Ekkehard ;
Markert, Udo R. .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 66 (04) :329-335
[5]   Natural killer cell lines in tumor immunotherapy [J].
Min Cheng ;
Jian Zhang ;
Wen Jiang ;
Yongyan Chen ;
Zhigang Tian .
Frontiers of Medicine, 2012, 6 (1) :56-66
[6]   Lipid Nanoparticle Systems for Enabling Gene Therapies [J].
Cullis, Pieter R. ;
Hope, Michael J. .
MOLECULAR THERAPY, 2017, 25 (07) :1467-1475
[7]   The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy [J].
Endo, Rikito ;
Nakamura, Takashi ;
Kawakami, Kyoko ;
Sato, Yusuke ;
Harashima, Hideyoshi .
SCIENTIFIC REPORTS, 2019, 9 (1) :11335
[8]   Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids [J].
Heyes, J ;
Palmer, L ;
Bremner, K ;
MacLachlan, I .
JOURNAL OF CONTROLLED RELEASE, 2005, 107 (02) :276-287
[9]   Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo [J].
Jayaraman, Muthusamy ;
Ansell, Steven M. ;
Mui, Barbara L. ;
Tam, Ying K. ;
Chen, Jianxin ;
Du, Xinyao ;
Butler, David ;
Eltepu, Laxman ;
Matsuda, Shigeo ;
Narayanannair, Jayaprakash K. ;
Rajeev, Kallanthottathil G. ;
Hafez, Ismail M. ;
Akinc, Akin ;
Maier, Martin A. ;
Tracy, Mark A. ;
Cullis, Pieter R. ;
Madden, Thomas D. ;
Manoharan, Muthiah ;
Hope, Michael J. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (34) :8529-8533
[10]   Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis [J].
Jiang, Wenzheng ;
Chai, Noo Ri ;
Maric, Dragan ;
Bielekova, Bibiana .
JOURNAL OF IMMUNOLOGY, 2011, 187 (02) :781-790